Comparison

HyperIn vs Mehidoc

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

HyperIn

This app facilitates internal communication and processes for commercial real estate properties. Access news, documents, contacts, and use a digital personnel card for benefits. It also supports regular sales reporting if required by your property.

Highlights
  • Internal news access
  • Document management
  • Contact directory
  • Digital personnel card
  • Sales reporting
  • Property-specific use
Features
Read full description

The HyperIn app brings your commercial real estate's internal communications and key processes to your mobile. With the HyperIn app, you can access property's internal news, important documents, contacts, and use your digital personnel card to claim internal benefits. You can also report the sales for your business regularly using the app, if reporting is required in your property. Use the app easily with the HyperIn account for your property. Please note that the application is intended for the property's internal use. The app must be separately taken into use for the property.

About

Mehidoc

Read full description

Mehidoc-sovellus on osa Mehiläisen Mehidoc-kokonaisuutta. Mehidoc ei ole pelkästään helppokäyttöinen ja intuitiivinen potilastietojärjestelmä, vaan se on Mehiläisen yhteistyökumppaneilleen ja terveydenhuollon ammattilaisille tarjoama digitaalinen, monikanavainen ja interaktiivinen työpiste. Mehidoc-sovelluksella pystyt hallitsemaan työskentelyä vapaasti ja reaaliajassa varaamalla vastaanottohuoneita ja muita resursseja haluamastasi yksiköstä vastaanottotyösi tueksi. Näet potilaittesi tulosyyt, ilmoittautumistilanteen ja voit järjestellä vastaanottopäivääsi tarpeen mukaan vielä samana päivänäkin esimerkiksi lisäämällä vastaanottoaikoja päivän päätteeksi. Sovellus antaa sinulle näkymän tilaamiesi tutkimusten tuloksiin ja voit lähettää sovelluksesta turvallisesti viestejä asiakkaallesi jatkohoidon varmistamiseksi. Sovellus tukee myös jokaisen Mehiläisen yhteistyökumppanin omaa kehittymistä tarjoamalla yksilökohtaisia kliinisiä tunnuslukuja sekä asiakkaiden palautteita. Sovelluksesta voit myös seurata reaaliajassa ansaintaasi menneiden ja seuraavien kuukausien tilitysten kautta.

Screenshots

HyperIn4 screens
Mehidoc4 screens

Verdict

The call

The clearest difference is update cadence: Mehidoc at fortnightly against HyperIn's every 2 months. HyperIn's advantage is iOS requirement (13.0 vs 15.6). On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

HyperIn ships an update every 2 months, Mehidoc fortnightly. The most recent releases landed on September 24, 2026 and September 15, 2026 respectively.

Scorecard2 real differences · 7 level
HyperIn versus Mehidoc: the parameters behind the verdict, then further details
ParameterHyperInMehidoc
PriceFreeFree
Rating5.0 (1 ratings) — better—
Number of ratings1 — better—
Update frequencyEvery 2 monthsFortnightly — better
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPodiPhone, iPad, iPod — better
Requires iOS13.0 — better15.6
Further details — not scored
Size37 MB28 MB
Age rating4+17+
DeveloperHyperIn OyMehilainen Oy

In-app purchases

None

HyperIn

No in-app purchases

None

Mehidoc

No in-app purchases

Questions

Is HyperIn free?
HyperIn is free to download, with no in-app purchases.
Is Mehidoc free?
Mehidoc is free to download, with no in-app purchases.
Do HyperIn or Mehidoc have ads?
Neither HyperIn nor Mehidoc shows ads.
Which is updated more often, HyperIn or Mehidoc?
HyperIn ships an update every 2 months, and Mehidoc fortnightly. Most recently, HyperIn was updated on September 24, 2026 and Mehidoc on September 15, 2026.

Other comparisons